The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF).

MedStar author(s):
Citation: European Journal of Heart Failure. 23(6):1052-1056, 2021 06.PMID: 33826209Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): LetterSubject headings: *Heart Failure | *Heart Failure, Systolic | Cardiac Myosins | Heart Failure, Systolic/dt [Drug Therapy] | Heart Failure/dt [Drug Therapy] | Humans | Stroke Volume | Urea/aa [Analogs & Derivatives]Year: 2021ISSN:
  • 1388-9842
Name of journal: European journal of heart failureAll authors: Claggett B, Felker GM, Honarpour N, Kurtz CE, Legg JC, Liu J, Malik FI, McMurray JJV, Minamisawa M, Papolos AI, Solomon SD, Sorensen TB, Teerlink JROriginally published: European Journal of Heart Failure. 2021 Apr 07Fiscal year: FY2021Digital Object Identifier: Date added to catalog: 2021-06-07
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 33826209 Available 33826209

English

Powered by Koha